Inter Pharma Stock

IP

TH9474010005

Pharmaceuticals

End-of-day quote Thailand S.E. Other stock markets 27/07/2026			5-day change	1st Jan Change
5.400 ^THB	0.00%		+4.85%	+17.39%

05-11	Inter Pharma Public Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
03-02	Inter Pharma Public Company Limited Reports Earnings Results for the Full Year Ended December 31, 2025	CI

Interpharma Public Company Limited is a Thailand-based company that develops, researches and distributes healthcare products and beauty initiatives for human beings, and healthcare products for animals. The Company provides wellness and anti-aging products, aesthetic innovation products, companion animal health products and livestock products. Its products include PREBO, YUUU toothpaste, multivitamin, Probac 7, Probac 10, Beta Glucan Plus, Pure Krill Oil, Astacurmin, YUUU cleansing mousse, Perfectha Complement, Perfectha Derm, Perfectha Deep, Perfectha Subskin and Uderma.

Employees

Sector

Pharmaceuticals

More about the company

Quotes

Date	Price	Change	Volume
27/07/26	THB 5.400	0.00%	381,027
24/07/26	THB 5.400	+1.89%	899,789
23/07/26	THB 5.300	+2.91%	499,551
22/07/26	THB 5.150	+0.98%	988,517
21/07/26	THB 5.100	+2.00%	277,769

End-of-day quote Thailand S.E.

More quotes

Income Statement and Estimates

More financial data

Annual profits - Rate of surprise

Company calendar

Market Cap	3.15B 93.75M 82.38M 76.9M 70.57M 132M 8.98B 135M 912M 357M 4.44B 352M 344M 15.36B	P/E 2024	52.3x	P/E 2025	22.8x
Enterprise Value	3.27B 97.31M 85.5M 79.81M 73.25M 137M 9.32B 140M 946M 370M 4.61B 365M 357M 15.94B	EV / Sales 2024	1.13x	EV / Sales 2025	1.31x
Free-Float	-	Yield 2024 *	-	Yield 2025	1.59%

05-11	Inter Pharma Public Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
03-02	Inter Pharma Public Company Limited Reports Earnings Results for the Full Year Ended December 31, 2025	CI
03-02	Inter Pharma Public Company Limited announces Annual dividend, payable on May 25, 2026	CI
11-12	Inter Pharma Public Company Limited (SET:IP) agreed to acquire an additional 49% stake in Interpharma- ZEAvita Company Limited from Thai Union Ingredients.	CI
11-11	Inter Pharma Public Company Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	CI
14/08/25	Inter Pharma Public Company Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025	CI
13/05/25	Inter Pharma Public Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2025	CI
16/04/25	Zhaoke Ophthalmology, Interpharma Strike Thailand Drug Distribution Deal	MT
16/04/25	Zhaoke Ophthalmology Limited Enters into Three Distribution and Supply Agreements with Interpharma Public Company Limited	CI
01/04/25	Inter Pharma Public Company Limited Signs Exclusive Distribution Agreement with Zhaoke Ophthalmology Company Limited for Comprehensive Eye Care Innovation	CI
25/02/25	Inter Pharma Public Company Limited Reports Earnings Results for the Full Year Ended December 31, 2024	CI
25/02/25	Inter Pharma Public Company Limited Proposes to Omit Dividend Payment for the Year Ended December 31, 2024	CI
14/11/24	Inter Pharma Public Company Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024	CI

17/08/22	Inter Pharma : New shares of IP to be traded on August 18, 2022	PU
10/08/22	Inter Pharma Public : Notification on Change of Directors and Authorization of Directors	PU
10/08/22	Inter Pharma Public : Report on the results of sale of common shares offered to private placement (F53-5)	PU
10/08/22	Inter Pharma Public : Right Adjustment of IP-W1 (Edited)	PU
10/08/22	Inter Pharma Public : Right Adjustment of IP-W1	PU

1 week	+4.85%
Current month	+21.08%
1 month	+20.54%
3 months	+32.35%
6 months	+25.00%
Current year	+17.39%

1 week	5.2	5.45
1 month	4.42	5.45
Current year	3.68	5.45
1 year	3.14	5.45
3 years	2.02	7.88
5 years	2.02	14.46
10 years	1.62	15.14

Inter Pharma Stock

Stocks

IP

TH9474010005

Pharmaceuticals

Valuation: Inter Pharma

Chart: Inter Pharma

Latest news : Inter Pharma

Press Releases: Inter Pharma

Quotes and Performance

Course Extremes

Managers and Directors: Inter Pharma

Latest insider transactions

Other Pharmaceuticals

Financials

Company Profile

Quotes

Income Statement and Estimates

Annual profits - Rate of surprise

Manager	Title	Age	Since
Trinnawat Thanitnithiphan CEO	Chief Executive Officer	56	01/02/2014
Chatkaew Krudkosol DFI	Director of Finance/CFO	56	23/06/2023
Chompunuch Meevang CMP	Compliance Officer	54	-

Director	Title	Age	Since
Kamtorn Sila-on BRD	Director/Board Member	56	08/02/2021
Udom Kachintorn CHM	Chairman	72	17/12/2019
Napaporn Dechakarat BRD	Director/Board Member	51	14/06/2017

Date	Insider	Type	Main position	Quantity	% Market Cap.
03/10/25	Trinnawat Thanitnithiphan	Buy	Chief Executive Officer	100,000	0.0165%
17/01/25	Trinnawat Thanitnithiphan	Buy	Chief Executive Officer	100,000	0.0165%
10/01/25	Trinnawat Thanitnithiphan	Buy	Chief Executive Officer	20,000	0.0033%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
INTER PHARMA	0.00%	+4.85%	+67.70%	-30.36%	97.36M
ELI LILLY AND COMPANY	-2.93%	-0.56%	+55.14%	+159.43%	1,079B
JOHNSON & JOHNSON	-3.33%	-0.12%	+54.83%	+54.58%	640B
ABBVIE INC.	-2.36%	+0.45%	+36.33%	+72.54%	465B
ROCHE HOLDING AG	-2.83%	+0.66%	+35.52%	+30.01%	353B
NOVARTIS AG	-2.08%	-0.23%	+34.03%	+39.85%	301B
ASTRAZENECA PLC	-2.91%	+0.36%	+10.74%	+13.83%	271B
NOVO NORDISK A/S	-2.17%	+3.23%	+1.74%	-39.45%	228B
AMGEN INC.	-1.49%	+3.08%	+27.06%	+63.54%	209B
GILEAD SCIENCES, INC.	-1.91%	-0.52%	+13.44%	+70.97%	165B
Average	-2.25%	+4.94%	+33.65%	+43.49%	370.98B
Weighted average by Cap.	-2.74%	+4.86%	+39.20%	+76.29%

	2024	2025
Net sales	1.91B 56.95M 50.04M 46.71M 42.86M 80.24M 5.45B 82.22M 554M 217M 2.7B 214M 209M 9.33B	2.21B 65.94M 57.94M 54.09M 49.64M 92.92M 6.32B 95.21M 641M 251M 3.13B 248M 242M 10.81B
Net income	37.28M 1.11M 976K 911K 836K 1.56M 106M 1.6M 10.8M 4.22M 52.63M 4.17M 4.08M 182M	122M 3.64M 3.2M 2.99M 2.74M 5.14M 349M 5.26M 35.45M 13.86M 173M 13.69M 13.39M 597M
Net Debt	209M 6.22M 5.47M 5.1M 4.68M 8.77M 596M 8.98M 60.52M 23.67M 295M 23.36M 22.85M 1.02B	119M 3.55M 3.12M 2.91M 2.67M 5.01M 340M 5.13M 34.56M 13.51M 168M 13.34M 13.05M 582M